PROGRAM

Wednesday April 2, 9.00-12.00 - Teaching course
Johan Zelano and Francesco Brigo

Conference room: Europa, Wallenberg Center

09.00-09.15 Welcome
Francesco Brigo, Johan Zelano 


09.15-10.00 Diagnosing epilepsy in other brain diseases 
Johan Zelano


10.00-10.30 Coffee break 


10.30-11.15 Epilepsy in patients with dementia 
Francesco Brigo


11.15-12.00 Management of seizures at and after stroke
Francesco Brigo and Johan Zelano


12.00 Lunch
for delegates at the Teaching course



Wednesday 2 April, 13.00-17.00 - STESS conference

Conference room: Wallenbergsalen

Session 1: Preclinical / epileptogenesis / disease modification

13.00-13.10 Opening remarks
Francesco Brigo and Johan Zelano


13.10-13.50  Preclinical multicenter-study of TBI in rodents: results and lessons learned from the EpiBioS4Rx
Asla Pitkanen, Finland


13.50-14.30 Interleukin-1 antagonism: an antiepileptogenic treatment?
Ronny Wickström, Sweden


14.30-15.00 Coffee break


15.00-15.40 Epilepsy in brain tumors: commonalities in tumorigenesis and epileptogenesis
Eleonora Aronica, the Netherlands


15.40-16.20  Antiepileptogenesis in first seizure-patients: too late or just right?
Tony Marson, UK


16.20-17.05 Platform session
3 x 15 min presentations


Welcome reception
 


Thursday 3 April - STESS Conference

Session 2: Biomarkers


08.20-09.00 Acute symptomatic seizures and their relation to poststroke epilepsy
Marian Galovic, Switzerland


09.00-09.40 Immune responses after seizures
Christine Ekdal, Sweden


09.40-10.20 The role of EEG in acute and structural epilepsies
TBA


10.20-10.50 Coffee break


10.50-11.30  Blood biomarkers in status epilepticus
Stefano Meletti, Italy


11.30-12.00 Blood biomarkers in chronic epilepsy
Johan Zelano, Sweden 


12.00-13.00  Lunch


Session 3: Diagnosis, treatment and prognosis

13.00-13.40 Epilepsy in Alzheimer’s disease
Francesco Brigo, Italy


13.40-14.20 Status epilepticus of acute and remote symptomatic etiology
Eugen Trinka, Austria


14.20-14.50 Coffee break


14.50-15.30 Autoimmune seizures
Stephan Ruegg, Switzerland


15.30-16.10 Antiepileptic drug treatment  in patients with brain tumors
Simona Lattanzi, Italy


16.10-17.00 Platform session
3 x 15 min presentations 


Friday 4 April - STESS Conference

Session 4: Prognosis continued, Hot topics 

09.00-09.40 Adverse cardiovascular events and ASM treatment
Josephine Mayer, UK


09.40-10.20 SUDEP in structural epilepsies
Alberto Vogrig, Italy


10.20-10.50 Coffee break


10.50-11.30  Long-term prognosis of structural epilepsy from an epidemiological perspective
Jakob Christenssen


11.30-12.10 Detecting epilepsy after eclampsia
Lina Bergman, Sweden


12.10  Lunch


Last update: 2024-09-25